Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast on Endothelial Function in COPD
NCT01595750Phase 4Unknown
- Sponsor
- CIBERES
- Start
- May 2012
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by CIBERES. Status: unknown.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01595750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01595750.